Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.001
Buy
RSI(14)
59.517
Neutral
STOCH(KDJ)(9,3,3)
69.471
Buy
ATR(14)
0.069
High Vlolatility
CCI(14)
104.371
Buy
Williams %R
15.086
Overbought
TRIX(12,20)
0.499
Sell
StochRSI(14)
100.000
Buy
Search
Myomo Inc
MYOAdd to Watchlist
0.910USD
+0.026+2.97%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
35.17MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Myomo Inc
Currency: USD Updated: 2026-05-15Key Insights
Myomo Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 77 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.32.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Myomo Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Myomo Inc Highlights
StrengthsRisks
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 112.71% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 40.93M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 40.93M.
Overvalued
The company’s latest PE is -2.53, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 23.44M shares, decreasing 19.96% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 3.09K shares of this stock.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
4.320
Target Price
+386.49%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of Myomo Inc is 6.63, ranking 132 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 10.11M, representing a year-over-year increase of 2.86%, while its net profit experienced a year-over-year increase of 13.15%.
Score
Financials
6.56
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.64
Operational Efficiency
6.35
Growth Potential
6.51
Shareholder Returns
7.11
Myomo Inc's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of Myomo Inc is 7.79, ranking 56 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.53, which is -89.52% below the recent high of -0.27 and -1586.89% above the recent low of -42.68.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 77/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15The current earnings forecast score of Myomo Inc is 8.00, ranking 66 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 10.00 and a low of 2.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
4.320
Target Price
+374.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
116
Total
6
Median
9
Average
Company name
Ratings
Analysts
Myomo Inc
MYO
5
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of Myomo Inc is 8.26, ranking 37 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.99 and the support level at 0.78, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.848
Buy
MA10
0.853
Buy
MA20
0.843
Buy
MA50
0.769
Buy
MA100
0.823
Buy
MA200
0.933
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-15Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Myomo Inc is 2.08, ranking 163 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.39. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.38
VaR
+7.89%
240-Day Maximum Drawdown
+78.59%
240-Day Volatility
+104.70%
Return
Best Daily Return
60 days
+14.63%
120 days
+14.63%
5 years
+41.81%
Worst Daily Return
60 days
-16.80%
120 days
-16.80%
5 years
-41.35%
Sharpe Ratio
60 days
+1.17
120 days
+1.00
5 years
-0.00
Risk Assessment
Maximum Drawdown
240 days
+78.59%
3 years
+90.84%
5 years
+97.12%
Return-to-Drawdown Ratio
240 days
-0.88
3 years
+0.17
5 years
-0.18
Skewness
240 days
-1.30
3 years
+0.86
5 years
+0.36
Volatility
Realised Volatility
240 days
+104.70%
5 years
+110.05%
Standardised True Range
240 days
+10.15%
5 years
+27.35%
Downside Risk-Adjusted Return
120 days
+152.09%
240 days
+152.09%
Maximum Daily Upside Volatility
60 days
+63.16%
Maximum Daily Downside Volatility
60 days
+54.35%
Liquidity
Average Turnover Rate
60 days
+0.99%
120 days
+1.31%
5 years
--
Turnover Deviation
20 days
-48.77%
60 days
-45.99%
120 days
-28.21%
Peer Comparison
Healthcare Equipment & Supplies
Myomo Inc
MYO
6.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
